相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors
Mark Levis et al.
BLOOD (2006)
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412
RM Stone et al.
BLOOD (2005)
Transport proteins and intestinal metabolism - P-glycoprotein and cytochrome P4503A
U Christians
THERAPEUTIC DRUG MONITORING (2004)
Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412
PA Campochiaro
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives
RB Caldwelll et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2003)
Transporter-enzyme interactions:: Implications for predicting drug-drug interactions from in vitro data
LZ Benet et al.
CURRENT DRUG METABOLISM (2003)
The kinase inhibitor PKC412 suppresses epiretinal membrane formation and retinal detachment in mice with proliferative retinopathies
Y Saishin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412
E Weisberg et al.
CANCER CELL (2002)
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C
DJ Propper et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
